<qa>  What is the goal of this prospective cohort trial?The effects of haploidentical rhG-CSF-mobilized unmanipulated blood and marrow transplantation HBMT on hematological malignancies are well established.The aim of this prospective cohort trial is to determine if acute graft-versus-host disease aGVHD could be decreased with IL2 therapy post HBMT.low dose of IL-2 40 million Um2 will be administered from WBC engraftment to day 90 post haploidentical transplantation. IL-2 will be administered three times a week. 